Pilot Study to Evaluate Immunopotentiating Effects of Immulina in Elderly Individuals
Completed · Not applicable · Has a placebo group
Conditions studied: Elderly Immune Senescence
In brief
This will be a small study aimed at determining the effects of oral Immulina consumption on the immune system in elderly individuals.
Key facts
- Study ID
- NCT01784692
- Run by
- University of Mississippi Medical Center
- People needed
- 21
- Starts
- 2013-04-01
- Expected to finish
- 2014-09-01
- Last updated by the study team
- 2016-05-26
Who can join
Age: 60 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age 60 and older;
- Generally otherwise healthy for age and not taking medications/supplements that could be expected to affect stress responses and/or impact immune parameters (example - systemic steroids, beta blockers, antidepressants, anti-anxiety drugs, Echinacea supplements, ginseng supplements or Spirulina supplements).
You may not qualify if…
- Inability to comprehend and speak English;
- Any history of major psychological or psychiatric illness (example - dementia, psychotic disorder, acute mania, current substance abuse) that may limit participant cooperation or compromise the integrity of self-reported clinical or psychological data;
- Presence of a confounding underlying systemic illness which could interfere with immunological profiles (example - severe cardiovascular, pulmonary, hepatic, gastrointestinal, renal, neurological, musculoskeletal endocrine , or metabolic systems; other gross physical impairments; or any history of significant convulsive disorder). Specifically, patients with congestive heart failure, recent viral or bacterial illness in the past 3 weeks, chronic kidney disease, thyroid disorder, autoimmune disease will be excluded.
Where it is running
- University of Mississippi Medical Center — Jackson, Mississippi, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.